Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI

NCT00537056 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Kidney Neoplasms
Carcinoma, Renal Cell
Kidney (Renal Cell) Cancer

Interventions

PROCEDURE: FDG PET CT
PROCEDURE: DCE MRI
DRUG: F-18 Fluoro-deoxi-glucose
DRUG: Gadolinium-DTPA
DRUG: Sunitinib

Sponsor

Stanford University

Collaborators

[object Object]